Author
Listed:
- Ivan N. Colaluca
(IFOM, the FIRC Institute for Molecular Oncology Foundation, Via Adamello 16, 20139, Milan, Italy
European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy)
- Daniela Tosoni
(IFOM, the FIRC Institute for Molecular Oncology Foundation, Via Adamello 16, 20139, Milan, Italy
European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy)
- Paolo Nuciforo
(IFOM, the FIRC Institute for Molecular Oncology Foundation, Via Adamello 16, 20139, Milan, Italy)
- Francesca Senic-Matuglia
(IFOM, the FIRC Institute for Molecular Oncology Foundation, Via Adamello 16, 20139, Milan, Italy)
- Viviana Galimberti
(European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy)
- Giuseppe Viale
(European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Chirurgia ed Odontoiatria, Università degli Studi di Milano)
- Salvatore Pece
(IFOM, the FIRC Institute for Molecular Oncology Foundation, Via Adamello 16, 20139, Milan, Italy
European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Chirurgia ed Odontoiatria, Università degli Studi di Milano)
- Pier Paolo Di Fiore
(IFOM, the FIRC Institute for Molecular Oncology Foundation, Via Adamello 16, 20139, Milan, Italy
European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Chirurgia ed Odontoiatria, Università degli Studi di Milano)
Abstract
NUMB's anticancer action The NUMB protein is involved in cell fate decisions via an interaction with a NOTCH family plasma membrane receptor, and plays a role in endocytosis. Its expression was known to be downregulated in human breast cancers. Now NUMB has been found to act as a tumour suppressor protein by inhibiting the ubiquitin ligase HDM2, thereby preventing the destruction of the major tumour suppressor p53. In addition, low levels of NUMB expression in breast tumours are found to be associated with a poor prognosis. These findings connect two areas of cell biology previously considered unrelated, and are of potential relevance for the design of rational therapies for cancer.
Suggested Citation
Ivan N. Colaluca & Daniela Tosoni & Paolo Nuciforo & Francesca Senic-Matuglia & Viviana Galimberti & Giuseppe Viale & Salvatore Pece & Pier Paolo Di Fiore, 2008.
"NUMB controls p53 tumour suppressor activity,"
Nature, Nature, vol. 451(7174), pages 76-80, January.
Handle:
RePEc:nat:nature:v:451:y:2008:i:7174:d:10.1038_nature06412
DOI: 10.1038/nature06412
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:451:y:2008:i:7174:d:10.1038_nature06412. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.